Overview of the 2022 WHO classification of thyroid neoplasms

ZW Baloch, SL Asa, JA Barletta, RA Ghossein… - Endocrine …, 2022 - Springer
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …

[HTML][HTML] Novel therapeutics in radioactive iodine-resistant thyroid cancer

T Fullmer, ME Cabanillas, M Zafereo - Frontiers in Endocrinology, 2021 - frontiersin.org
Iodine-resistant cancers account for the vast majority of thyroid related mortality and, until
recently, there were limited therapeutic options. However, over the last decade our …

[HTML][HTML] RBM47/SNHG5/FOXO3 axis activates autophagy and inhibits cell proliferation in papillary thyroid carcinoma

Y Qin, W Sun, Z Wang, W Dong, L He, T Zhang… - Cell death & …, 2022 - nature.com
Papillary thyroid carcinoma (PTC) is the main type of thyroid carcinoma. Despite the good
prognosis, some PTC patients may deteriorate into more aggressive diseases, leading to …

[HTML][HTML] Novel inhibitor-based therapies for thyroid cancer—An update

M Ratajczak, D Gaweł, M Godlewska - International journal of molecular …, 2021 - mdpi.com
Thyroid cancers (TCs) are the most common tumors of the endocrine system and a constant
rise in the number of TC cases has been observed for the past few decades. TCs are one of …

[HTML][HTML] Dynamic cancer cell heterogeneity: Diagnostic and therapeutic implications

V Jacquemin, M Antoine, G Dom, V Detours… - Cancers, 2022 - mdpi.com
Simple Summary Cancer heterogeneity, which occurs in most cancer patients, has been
known and studied by experienced pathologists since the early 19th century. Intratumoral …

[HTML][HTML] Poorly differentiated thyroid carcinoma: a clinician's perspective

J Tong, M Ruan, Y Jin, H Fu, L Cheng… - European Thyroid …, 2022 - etj.bioscientifica.com
Poorly differentiated thyroid carcinoma (PDTC) is a rare thyroid carcinoma originating from
follicular epithelial cells. No explicit consensus can be achieved to date due to sparse …

[HTML][HTML] Update on current diagnosis and management of anaplastic thyroid carcinoma

ET Pavlidis, IN Galanis, TE Pavlidis - World Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Well-differentiated thyroid carcinoma has a favorable prognosis with a 5-year survival rate of
over 95%. However, the undifferentiated or anaplastic type accounting for< 0.2%, usually in …

NEAT1_2/RRAD/EHF positive feedback loop facilitates aerobic glycolysis in papillary thyroid cancer cells

W Sun, Z Wang, Y Qin, X Ji, J Huang, F Zhang… - …, 2023 - academic.oup.com
Papillary thyroid carcinoma (PTC) is the most prevalent endocrine-related malignancy. In
spite of the good prognosis, a more aggressive disease can develop in some PTC patients …

[HTML][HTML] Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production

DB Allison, J Rueckert, V Cornea, CY Lee, J Dueber… - Endocrine …, 2022 - Springer
In this report, we present a high-grade thyroid carcinoma with an NSD3:: NUTM1 fusion
detected on expanded next-generation sequencing testing. Nuclear protein of the testis …

Thyroid cancer under the scope of emerging technologies

M Tarabichi, P Demetter, L Craciun, C Maenhaut… - Molecular and cellular …, 2022 - Elsevier
The vast majority of thyroid cancers originate from follicular cells. We outline outstanding
issues at each step along the path of cancer patient care, from prevention to post-treatment …